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Early, trauma-focused intervention development has emphasized unidirectional trajectories that begin
with basic research and efficacy trials followed later by effectiveness and dissemination studies. In
this article, the authors present methods derived from social and clinical epidemiology that constitute
foundational research in the development of early trauma-focused intervention. They also describe how
population-based practice research may serve to feed back and inform what has been conceptualized
as earlier stages of intervention development such as efficacy trials. Examples of relevant epidemiologic
research methods are presented to illustrate these points. The authors posit that the continued application
of population-based methods may produce treatments that can be feasibly applied to the unique patient,
provider, organizational, and community contexts relevant to early interventions for survivors of trauma.
Psychopharmacological and psychotherapeutic inter-
vention development has often been conceptualized as
moving along a continuum from basic research through
efficacy trials to investigations that test intervention effec-
tiveness and ultimately widespread dissemination (Holder
et al., 1999; Rounsaville, Carroll, & Onken, 2001; Weisz,
Chu, & Polo, 2004). To date, this bench-to-bedside con-
ceptualization of treatment development may be seen as the
predominant framework informing early trauma-focused
interventions (Davis, Barad, Otto, & Southwick, 2006;
Foa & Meadows, 1997; Litz, Gray, Bryant, & Adler,
2002; National Institute of Mental Health, 2002). Other
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commentary has suggested that diverse investigative de-
signs that vary across efficacy, effectiveness, and dissemi-
nation/practice research paradigms may optimally inform
the development of interventions that are feasibly and ef-
fectively delivered in real-world settings (Kazdin, 2001;
National Institute of Mental Health, 1999; Southam-
Gerow, Ringeisen, & Sherrill, 2006; Street, Niederehe,
& Lebowitz, 2000; Weisz et al., 2004; Zatzick, Simon,
& Wagner, 2006). There exists, however, a paucity of
discussion in the peer-reviewed literature of how diverse
methodological approaches can inform the development of
early, trauma-focused intervention. The current overview
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Figure 1. The contribution of epidemiological studies to early intervention development. 1 = Basic investigation of variations in
posttraumatic biological parameters. 2 = Practice research informs earlier phases of intervention development. 3 = Epidemiological
studies inform combined, stepped-care interventions. Practice research is defined as investigation that examines how and which
treatments or services are actually provided to individuals within real-world service delivery contexts (National Institute of Mental
Health, 1999). Adapted from Bridging Science and Service: A Report by the National Advisory Mental Health Council’s Clinical
Treatment and Services Research Workgroup (NIH Publication No. 99–4353), by National Institute of Mental Health, 1999,
Bethesda, MD: National Institute of Mental Health.
addresses this gap by providing one conceptual framework
for and examples of how population-based epidemiological
investigation can contribute to the development of early,
trauma-focused interventions (Figure 1).
E P I D E M I O L O G I C M E T H O D S A N D
I N T E R V E N T I O N D E V E L O P M E N T
Broadly speaking, epidemiology is the science that de-
scribes the distribution of diseases and attempts to elucidate
associations between disease determinants and specific dis-
ease states (Rothman & Greenland, 1998). Prior commen-
tary has conceptualized epidemiologic research as a basic
science in the development of medical and psychosocial in-
terventions (Greenwald, 1984; Holder et al., 1999; Shrout,
1998). Epidemiology, as a foundational science for inter-
vention development, can serve to define the incidence
and prevalence of specific disorders and aid in the estab-
lishment of working causal models of a disorder, including
the elucidation of risk and protective factors (Holder et al.,
1999). We note here that the role of epidemiology in iden-
tifying causes of disease has been the subject of substantial
debate in the literature (Kundi, 2006; Susser, 1997). We
use here the more general word determinant (Susser, 1991)
to refer to factors that are statistically demonstrated to be
associated with health indicators of interest, taking no side
in the debates about whether epidemiologic inquiry can
genuinely understand causality, or identify causes.
In the past few decades, as epidemiology has ma-
tured as a science, different branches of epidemiology
have emerged. Psychiatric epidemiology, as one of these
branches, is concerned with the study of the distribu-
tion and determinants of psychiatric disorders in the gen-
eral population (Galea, Nandi, & Vlahov, 2005; Insel &
Fenton, 2005). One of the key challenges with which epi-
demiologists have grappled during the past decade is the
scope of the determinants that constitute areas of inter-
est and focus for epidemiology. This has often been re-
ferred to as epidemiology that is concerned with levels of
etiology and inquiry. For many of the early years of epi-
demiology’s formation as a discipline, the central focus
of epidemiologic research interest was on the individual
level and individual risk factors for diseases. These risk fac-
tors were primarily individual behaviors or environmen-
tal exposures that affected individuals. Recently, however,
there has been growing interest in pushing the bound-
aries of epidemiologic inquiry beyond the individual, to
include an individual’s context, such as characteristics of
communities of residence and interactions with the health
care system. Social epidemiology has evolved as a specific
area of epidemiology focusing on context and the social
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determination of health and disease, although, broadly
speaking and relevant to this discussion, social epidemi-
ology offers a lens through which all disease causation
can be understood. Therefore, for this discussion, we re-
fer to social/psychiatric epidemiology to mean etiologic
population-based inquiry that is concerned with causation
at multiple levels.
In contrast, clinical epidemiology can be understood
as the science of making predictions about individual pa-
tients by describing clinical phenomena (e.g., psychiatric
symptoms, medical comorbidities) in populations of pa-
tients (Fletcher, Fletcher, & Wagner, 1996). Clinical epi-
demiology aims to frame the care of the individual pa-
tient in the context of the larger population of patients
that present for care in a specified health service delivery
setting.
Social and clinical epidemiology share in common a
multifactorial approach to the understanding of disease
causality and amelioration (Rothman & Greenland, 1998).
Epidemiologic approaches to understanding causal associ-
ations emphasize the examination of a broad spectrum of
evidence, including the strength of an association, iden-
tification of a temporal relationship in which the deter-
minant precedes the disorder, consistency in the repeated
observation of an association across different populations,
specificity with regards to a single determinant leading to
a single effect, observation of a biological gradient or dose-
response relationship between determinant and effect, bi-
ological plausibility, coherence in the sense that what is
known about the association does not conflict with what
is known about the disease process, analogy to disease
processes for other disorders, and experimental evidence
supporting the association or amelioration of the condi-
tion when a hypothesized determinant is targeted in ran-
domized clinical trial designs (Chilcoat & Breslau, 1998;
Rothman & Greenland, 1998). Reliance upon this spec-
trum of information to elucidate causal associations has
necessitated that social and clinical epidemiologic investi-
gators be familiar with a range of investigative designs that
include randomized clinical trials as well as cross-sectional
and prospective cohort designs (Feinstein, 1985; Rothman
& Greenland, 1998).
Epidemiology is a population-based science; therefore,
inference is drawn from studies among population groups
and about population aggregate risks and rates. Both social
and clinical epidemiological investigations strive to attain
external validity through representative sampling proce-
dures that emphasize the inclusion of a quantifiable de-
nominator in the investigative design. Social/psychiatric
epidemiology and clinical epidemiology can be distin-
guished by thinking through the question, “What is the
denominator?” In classic psychiatric epidemiology the ideal
denominator is the general population (Kessler, Sonnega,
Bromet, Hughs, & Nelson, 1995; Wang et al., 2005).
For trauma-focused psychiatric epidemiology, the entire
trauma-exposed population often constitutes the denomi-
nator (Galea et al., 2002; Hoge, Auchterlonie, & Milliken,
2006; Kulka et al., 1990; Norris et al., 2002). This is illus-
trated in Figure 2 as all individuals within a trauma-exposed
region. For clinical epidemiology, the denominator can be
defined by a population of patients that present to a partic-
ular clinical setting (Feinstein, 1985). For example, clinical
epidemiological studies of injured trauma survivors con-
ducted in acute care medical settings define the population
of patients admitted to a trauma center during the time pe-
riod of the study as the denominator (Zatzick, Grossman
et al., 2006; Zatzick et al., 2004). This is illustrated in
Figure 2 by the encapsulation of individuals within health
care organizations. In studies of health care systems, the
denominator may include all organizations within a par-
ticular geographic region (Figure 2; Mackenzie et al., 2006;
Zatzick et al., 2007).
Barriers in the widespread dissemination of evidence-
based practice to real-world treatment settings may arise
from aspects of the intervention development processes
that fail to adequately take the influence of contextual
factors on treatment implementation into consideration
(Glasgow & Emmons, 2007; Zatzick, Simon, et al., 2006).
A central difficulty may be the lack of focus on issues of
external validity up-front in the research design. As a re-
sult, investigations establishing the efficacy of interventions
may suffer from the inclusion of nonrepresentative sam-
ples of patients, providers, and health care organizations
(Spinazzola, Blaustein, & van der Kolk, 2005).
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Figure 2. An example of multiple potential denominators in a trauma-focused social and clinical epidemiologic investigation.
The first denominator is defined as all individuals within a trauma-exposed region. A second denominator might consist of the
subpopulation of individuals within a single trauma exposed community (e.g., individuals in Community I). A third potential
denominator is all trauma-exposed individuals presenting to a single health care organization, such as a level I trauma center (e.g.,
individuals presenting to organization A). A fourth denominator could be defined as all health care organizations within a trauma
exposed region (e.g., Organizations A, B, C, and D).
Glasgow and Emmons (2007) have articulated a mul-
tifactorial model of the types of evidence required for a
comprehensive understanding of contextual factors in the
translation of efficacious interventions to real-world treat-
ment settings. Theoretical rationale/mechanism of action
and efficacy data are two crucial domains of evidence re-
quired. Beyond these domains, information regarding ex-
ternal validity/generalizability, including data on the fea-
sibility of intervention delivery in representative practice
settings, cost, and economic data, and ongoing quality
improvement/safety information may also be required for
successful widespread dissemination.
We posit that population-based epidemiological inves-
tigation is an ideal method for systematically obtaining pa-
tient, provider, organizational, and community contextual
data required for the development of robustly delivered
early, trauma-focused interventions. In the next section,
we provide specific case examples of how social and clinical
epidemiological investigations constitute basic research on
intervention development and how practice and dissemi-
nation research clearly feed back to inform what has been
previously conceptualized as earlier stages of intervention
development (Figure 1). The examples we consider here
discuss how representative samples can be invaluable in
investigations concerned with the genetic/molecular de-
terminants of psychopathology, pharmacologic prevention
of posttraumatic stress disorder (PTSD), and early PTSD
intervention trials. We refer to specific pathways and ele-
ments from Figure 1 throughout our discussion of each of
these examples.
Journal of Traumatic Stress DOI 10.1002/jts. Published on behalf of the International Society for Traumatic Stress Studies.
An Epidemiologic Approach to Early Intervention 405
E X A M P L E S O F T H E P O T E N T I A L
C O N T R I B U T I O N S O F S O C I A L A N D C L I N I C A L
E P I D E M I O L O G Y T O T H E D E V E L O P M E N T O F
E A R L Y , T R A U M A - F O C U S E D I N T E R V E N T I O N
Example 1. Population Sampling and Genetic
Determinants of Psychopathology
Traditionally, etiologic research that is concerned with
the determination of particular psychopathologies is con-
ducted among highly selected (and predominantly ho-
mogenous) groups of persons enrolled in clinical settings
(see Figure 1, Pathway 1; Galea et al., 2006). The principal
rationale for using such highly selected groups for the pur-
poses of genetic/molecular inquiry is that having homoge-
nous persons enrolled in a particular study minimizes inter-
person variation and the confounders that such variation
may introduce, complicating the particular gene/molecule
and disease association of interest. However, this approach
has the potential to obscure important insight about the eti-
ologic mechanisms that operate in influencing pathogen-
esis. As discussed above, epidemiologists have articulated
multifactorial causal formulations. From this perspective,
much of what we may typically think of as a cause for
disease is actually a component cause of a larger sufficient
cause. It is the constellation of component causes that make
up a sufficient cause for pathogenesis. There are many (per-
haps an infinite number) of sufficient causes of any par-
ticular disease, each constituted of their own component
causes. This heuristic has the advantage of explaining why
it is that persons with a particular cause do not always have
disease. Consider component cause X, which is a well-
recognized risk factor for disease Y. Although component
cause X may be a part of many sufficient causes for disease
Y (hence the presence of that component cause X confer-
ring high risk on a person for disease etiology), the absence
of the other component causes that need to co-occur with
component cause X may mean that a particular individual
does not develop disease Y. Conversely, the presence of even
a few sufficient causes that do not involve component cause
X means that persons without cause X (persons at low risk
because there are only a few sufficient causes that do not
involve X) can still develop disease Y. This heuristic can
then help us understand why population-based epidemio-
logic methods are necessary if we want to understand the
true nature of genetic/molecular determination of disease.
To illustrate this, let us assume that we can produce a par-
ticular psychopathology of interest P in three ways (and
only three ways); i.e., there are three sufficient causes of
PTSD. And let us also assume that these sufficient causes
are as follows:
 Sufficient Cause 1: Requires the co-occurring presence
of factors G1, factor S1, and factor U. Let us assume
that G1 is a particular gene, S1 is a particular social
factor and U is the set of all other unmeasured factors.
 Sufficient Cause 2: Following the same notation as
above, requires the co-occurring presence of factors
G2 (another particular gene), and factor U.
 Sufficient Cause 3: Requires the co-occurring presence
of only factors S2, another particular social factor and
factor U.
Now suppose that each of these sufficient causes are
present in a third of the population; that is, that a third
of the population has factors G1, S1, and U, a third have
G2 and U, and a third have S2 and U. If we were to
then conduct a study that selects from a narrowly defined
group of persons (e.g., persons from a local emergency
department) we may select only persons who have factors
G2, S2, and U; it is entirely possible (especially if our
recruitment is highly selective) that we do not find anyone
with factors S1 or factors G1. In so doing, we may then have
disease causation predicated on causes 2 and 3 only, and we
may well conclude that factors G2 (i.e., a genetic factor)
or factor S2 (i.e., a social factor) are both causes of PTSD,
but that there is no biologic interaction between genetic
or social factors in the cause for PTSD. Now, conversely, if
in a different sample, we select people who only happen to
have factors G1 and S1, we may well not even notice that
these factors are component causes for PTSD because they
are ubiquitous and hence there is no variability in relation
between exposure (constellation of sufficient causes) and
outcome. Both these inferences would of course be false.
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The truth is that there are multiple avenues of causation
for disease P, including interaction between factors G1 and
factor S1, but that this interaction is not detected in either
scenario when we failed to sample persons in whom the
interaction exists, or to sample in such a way that we notice
that there are indeed multiple causal genes that are not
sampled in a particular homogenous sample. Therefore,
population-based sampling can provide an opportunity to
much more accurately elucidate the joint contribution of
genetic/molecular and social causes to disease etiology.
Example 2. Epidemiologic Investigation of Psychiatric
Comorbidities Informs Early Combined Intervention
There is an abundance of epidemiologic evidence that
PTSD co-occurs with other mood, anxiety, and sub-
stance related comorbidities (Hoge et al., 2004; Kessler
et al., 1995; Kulka et al., 1990). Galea and colleagues’
population-based investigations after the September 11,
2001 World Trade Center terrorist attack documented high
frequencies of PTSD symptoms as well as comorbid de-
pressive symptoms and increases in alcohol and tobacco
use (Boscarino, Adams, & Galea, 2006; Galea et al., 2002;
Vlahov, Galea, Ahern, Resnick, Boscarino, et al., 2004;
Vlahov, Galea, Ahern, Resnick, & Kilpatrick, 2004). For
example, this series of studies found that the prevalence
of drinking problems was 3.7% in the 6 months before
September 11 and 4.2% in the 6 months after September
11. The incidence of drinking problems among those with-
out drinking problems before September 11 was 2.2%.
Persons with incident drinking problems were more likely
than those without to report symptoms consistent with
PTSD (17.4% vs. 0.4% in those without drinking prob-
lems and 1.4% in nondrinkers) and depression (23.5%
vs 5.6% vs. 4.9%, respectively) after September 11, 2001
(Vlahov et al., 2006). See Figure 1, Pathways 1 and 3 (Galea
et al., 2002; Vlahov, Galea, Ahern, Resnick, Boscarino
et al., 2004; Vlahov, Galea, Ahern, Resnick, & Kilpatrick,
2004; Zatzick et al., 2004).
These data are consistent with findings in other disaster-
exposed populations. For example, Reijneveld, Crone,
Verhulst, and Verloove-Vanhorick (2003) found PTSD,
depressive, and alcohol use symptoms were elevated among
Dutch adolescents exposed to a café fire. Interestingly,
as with the September 11, 2001 terrorist attacks, long-
term follow-up demonstrated sustained elevations in al-
cohol use, while PTSD and depressive symptoms dimin-
ished (Reijneveld, Crone, Schuller, Verhulst, & Verloove-
Vanhorick, 2005). An epidemiologic approach to early in-
tervention development might use these findings as foun-
dational research to inform the development of early com-
bined interventions targeting not only PTSD, but also
highly prevalent mood and substance-related morbidities.
An important corollary to this observation is that epi-
demiological investigation may also incorporate measures
of the public health burden of specific disorders, such as the
population attributable fraction (PAF), attributable years
of life lost, and disability adjusted life years, to fully describe
the burden of disease that attends traumatic event expo-
sure and to more fruitfully inform the evaluation of com-
bined intervention procedures (Steenland & Armstrong,
2006). For example, evidence suggests that PTSD may
be a risk factor for a variety of chronic medical condi-
tions (Schnurr & Green, 2004). Also, alcohol misuse in
trauma-exposed populations may be associated with ad-
ditional morbidity/mortality secondary to recurrent trau-
matic injury (Gentilello et al., 1999; Hearst, Newman, &
Hulley, 1986). Thus, population-based prospective cohort
investigations that incorporate PAF estimates for PTSD
and related comorbidities could inform the staging and se-
quencing of early combined intervention procedures that
target the primary and secondary prevention of PTSD and
related comorbidities.
Example 3. Practice Research Informs Basic and
Efficacy Research in Secondary PTSD Prevention
The theoretical rationale for a diverse group of candidate
compounds as early intervention agents in the secondary
psychopharmacologic prevention of PTSD has been artic-
ulated (Friedman, 2002; Morgan, Krystal, & Southwick,
2003; Pitman & Delahanty, 2005; Schoenfeld, Marmar,
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& Neylan, 2004). Among these potential agents, corti-
costeroids and beta-adrenergic antagonists have recently
been selected for initial efficacy trials (Pitman et al., 2002;
Schelling et al., 2004; Stein, 2005; Vaiva et al., 2003). See
Figure 1, Pathway 2 (Zatzick & Roy-Byrne, 2006).
Preventive pharmacotherapeutic intervention targeting
PTSD is hypothesized to begin optimally early after the
traumatic event (Friedman, 2002; Pitman & Delahanty,
2005). At the time of surgical inpatient discharge, injured
patients are typically off intravenously administered medi-
cation and follow-up care is being planned. Thus, hospital
discharge may be a key time point to initiate medications
targeting the secondary prevention of PTSD among in-
jured trauma survivors (Zatzick & Roy-Byrne, 2006).
However, delivery of interventions in acute care is com-
plicated by a number of patient, provider, and service
delivery contextual factors that, when explored through
population-based investigation, may serve to inform which
of the many medications with strong theoretical rationales
for secondary PTSD prevention can be feasibly delivered
early on posttrauma. Data from 2,931 patients recruited
from 69 acute care inpatient hospitals nationwide sug-
gests that, along with early posttraumatic distress, physical
pain complaints within 2–3 months postinjury are sig-
nificantly and independently associated with an increased
risk of symptoms consistent with a diagnosis of PTSD 12
months after injury hospitalization (Zatzick et al., 2007).
Another population-based clinical phenomenological in-
vestigations has demonstrated that patients are predomi-
nantly concerned with physical health and bodily pain in
the days and weeks after injury; psychological concerns
such as anxiety and depressive symptoms are less prevalent
within the days after the injury but steadily increase over the
ensuing months (Zatzick et al., 2001; Zatzick et al., 2007).
These observations informed a pharmacoepidemio-
logic investigation of medication prescription by surgical
providers at the time of acute care hospital discharge. Medi-
cation prescription at the time of hospital discharge for ran-
domly selected adolescent (n = 113) and adult (n = 152)
injury survivors was assessed by review of automated med-
ical records. Opiate analgesics were prescribed for 80%–
90% of patients, and nonopiate analgesics to 34%–46%
of patients. Corticosteroids, beta-adrenergic blockers, and
other psychotropic medications were prescribed to less than
10% of patients (Zatzick & Roy-Byrne, 2006).
The results of this pharmacoepidemiologic investigation
substantiate the ubiquitous use of analgesic medication in
the acute care inpatient setting. These data, when taken
into consideration with preclinical data suggesting opi-
ates may prevent memory consolidation through a beta-
adrenergic mechanism (McGaugh, Introini-Collison, &
Nagahara, 1988; Morgan et al., 2003), suggest initial feasi-
bility tests and efficacy trials of compounds targeting pain
in the secondary prevention of PTSD after injury. These
results might also stimulate basic research on compounds
that simultaneously target pain and anxiety. The findings
demonstrate how population-based data derived from real-
world practice settings can enhance the efficiency and tra-
jectories of pharmaceutical intervention development in
the secondary prevention of PTSD.
Example 4. How Population-Based Sampling
Can Enhance the External Validity of Early Intervention
Trials
Randomized controlled trials have established the efficacy
of psychotherapeutic and psychopharmacological treat-
ments in the treatment of posttraumatic stress disorder
(PTSD) and related comorbid conditions, and guide-
lines derived from these studies have been developed
(Department of Veterans Affairs, 2003; Foa, Keane, &
Friedman, 2000; Ursano et al., 2004). Despite these ad-
vances many individuals either go untreated or do not
receive guideline-concordant PTSD care (Katon, Zatzick,
Bond, & Williams, 2006).
A key issue for the development of early, trauma-focused
intervention is that treatments derived from efficacy trials
developed in mental health specialty settings may require
adaptation to be feasibly delivered in real-world early in-
tervention settings. For example, the standardized regular
appointments and intact health service delivery systems
that constitute an implicit foundation of treatment de-
livery in efficacy trials are often impossible to attain in
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early posttraumatic treatment contexts such as postdisaster
or acute care medical settings (Sabin, Zatzick, Jurkovich,
& Rivara, 2006). Also, population-based clinical investi-
gation suggests that, in contrast to the highly motivated
patients recruited into efficacy trials, patients in the early
aftermath of trauma experience multiple other posttrau-
matic concerns that extend beyond seeking treatment for
PTSD (Zatzick et al., 2001; Zatzick et al., 2007). The
process of adaptation might necessarily begin with social
and clinical epidemiological investigations that character-
ize the early posttraumatic individual, provider, organiza-
tional, and community contexts relevant to the implemen-
tation of early, trauma-focused interventions.
One manner in which the acute care traumatic injury
research programs have operationalized an epidemiologi-
cal approach to intervention development is through the
use of population-based automated data systems (Simon,
Unutzer, Young, & Pincus, 2000; Zatzick et al., 2000). The
population-based automated data systems provide clinical
and demographic information on all patients treated within
the acute care inpatient setting so that characteristics of an
individual patient or subgroup of patients included in an
investigation can be compared to the population of patients
presenting for care (Figure 2).
Typically, a series of prospective cohort and cross-
sectional investigations leads to randomized trials. These
preparatory investigations use the data systems (in con-
junction with structured clinical assessments) to gain in-
sight into the processes of care underlying the detection
of patients with mental health symptoms/diagnoses (Sabin
et al., 2006; Zatzick et al., 2005), to characterize the symp-
tomatic presentation and trauma histories of patients to be
targeted in a clinical trial (Zatzick, Grossman, et al., 2006;
Zatzick et al., 2002), and to characterize population uti-
lization and cost parameters (Zatzick et al., 2000). The
automated data systems can also provide key data related
to policy-relevant outcome domains, such as emergency
department and inpatient surgical surveillance data doc-
umenting recurrent injury admissions (Gentilello et al.,
1999).
With regard to the actual conduct of randomized clinical
trials, the automated data systems allows the first portion
of the results section of the trial to ask how the clinical
and demographic characteristics of individuals included
in the investigation compare to the population of eligible
patients admitted to the trauma center during the time
period of the study. The first table or paragraph of the
manuscript’s results section compares the clinical, injury,
and demographic characteristics of participating patients
with the characteristics of the population of patients ad-
mitted to the trauma center (Zatzick, Grossman, et al.,
2006; Zatzick et al., 2002; Zatzick et al., 2004). Over-
all, the clinical, demographic, and injury characteristics of
patients included in the acute care prospective and ran-
domized clinical trials investigations have not significantly
differed from the characteristics of the injured population,
with the exception of inpatient length of stay.
In an effort to understand bias introduced by longer in-
patient stays in study patients, other trauma registry inves-
tigations have assessed the characteristics of patients who
are discharged early from the hospital (Zatzick et al., 2000).
In a trauma registry investigation of over 10,000 inpatient
admissions, patients with alcohol abuse/dependence diag-
noses demonstrated a 10% reduction in inpatient length
of stay; thus, patients with these diagnoses may be under-
represented in the study samples. In summary, the use of
automated trauma registry data allows for the assessment
of generalizability and bias in acute care inpatient clinical
trial sampling.
C O N C L U S I O N S
The four examples presented demonstrate how the
population-based approaches of social and clinical epi-
demiology can productively contribute to the development
of early, trauma-focused interventions. Contributions can
occur at multiple levels, including foundational research
that informs intervention development and also redirec-
tion of treatment development trajectories towards more
efficiently and robustly applied real-world interventions.
Pioneers in key fields that have informed the develop-
ment of trauma-focused intervention such as clinical psy-
chology have been equally concerned with issues of external
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validity (Bronfenbrenner, 1977; Campbell, 1957; Mook,
1983). Clinical psychologists have raised questions about
the extension of data derived from experimental designs
to social settings (Campbell, 1957) and regarding the eco-
logical validity of experimental findings (Bronfenbrenner,
1977, 1979). Public health approaches to the development
of early, trauma-focused interventions would suggest that
to develop ecologically valid interventions, external valid-
ity/generalizability assessments should be more fastidiously
incorporated upfront into the design and implementa-
tion of clinical investigations (Glasgow & Emmons, 2007;
Zatzick, Simon, et al., 2006).
The approaches presented here aim to systematically in-
corporate considerations regarding patient, provider, orga-
nizational, and community context into the development
and implementation of early, trauma-focused interventions
(Figure 2). The use of population-based sampling pro-
cedures and registry information systems operationalizes
methods to enhance assessments of generalizability.
We recognize that encouraging early intervention re-
searchers to develop the methodological expertise re-
quired for population-based investigation may be ardu-
ous. Although there have been increasing calls for such
work, relatively few studies have yet been carried out
that use population samples to consider questions related
to biologic etiology (Cacioppo, Berntson, Sheridan, &
McClintock, 2000; Galea et al., 2006). We suspect that
the principal barrier to the establishment of such studies is
not so much cost, as the technical and intellectual flexibility
to implement such studies. Solutions, however, are emerg-
ing. Population-based automated data analyses on existing
information systems, such as the pharmacoepidemiolgical
investigation described in Example 3 are remarkably inex-
pensive. An approach that may overcome barriers to devel-
oping needed methodological expertise is the cultivation of
interdisciplinary teams that augment research groups com-
prised primarily of psychologists, psychiatrists, and other
mental health investigators with collaborators from diverse
social scientific (e.g., economics, anthropology), medical
(e.g., internal medicine, pediatrics, surgery), and public
health backgrounds (Pellmar & Eisenberg, 2000; Zatzick,
Simon, et al., 2006). As discussed here, incorporation of
these methods promises to advance early-intervention sci-
ence substantially.
It is well established that the causes of psychopathology
after traumatic exposure are multifactorial. However, con-
sidering only one factor (in this case traumatic exposure)
as central to early intervention, absent of a full consid-
eration of the role of context, has produced treatments
that do not broadly generalize to trauma-exposed popu-
lations. Ultimately, interventions that are predicated on a
restricted sampling frame may hold diminished relevance
when applied to broader real world contexts. Although a
well-designed randomized efficacy trial may demonstrate a
large effect size in a homogenous sample, the intervention
may need augmentation if it is to be broadly implemented
with the heterogeneous populations that characterize real-
world early intervention settings. Ultimately, the multifac-
torial influence of context stacks the deck against interven-
tions informed only by one risk factor and suggests results
that, in a practical sense, are unattainable. We hope that
the approaches proposed here—applying population-based
methods to understand fully the unique and relevant pa-
tient, provider, organizational, and community contexts—
may help in the development of feasibly applied, effective,
early interventions to mitigate the multiple adverse conse-
quences of individual and mass trauma.
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